Middleman and AI-Media Enter New Ad Insertion Partnership BROOKLYN, N.Y., Aug. 31, 2023 (GLOBE NEWSWIRE) — AI-Media, and Middleman Software, Inc., a leading provider of SCTE 104 and 35 messaging solutions, have joined forces to offer broadcasters a powerful, unified SCTE 104/35 messaging solution for live production workflows. AdIT: Middleman Software’s AdIT Live revolutionizes the generation of […]
PHOENIX, Aug. 31, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in innovative temporary space solutions, today announced that Tim Boswell, President and Chief Financial Officer, and Nick Girardi, Senior Director of Treasury and Investor Relations, will participate in a presentation and […]
Foothill Ranch, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) — Global sweetness and flavor innovator Sweegen has announced that its Bestevia® Rebaudiosides M (Reb M), D, and E have received full authorization from the Taiwan FDA for use in food and beverages. This recent regulatory approval marks another milestone in Sweegen successfully opening new markets in […]
Platform growth and integrations leading to increased revenue and improved margins Highlights of Q2 2023 Increased earnings driven by revenue growth and ongoing cost savings Net revenue of approximately € 122 million for Q2 2023, up from € 104 million in Q2 2022. Adjusted EBITDA of almost € 19 million, up by approximately 58% compared […]
Fluence’s India Innovation Centre, located in Bangalore, will serve as a global center of excellence to support Fluence’s rapid growth in providing customers with market-leading energy storage products, services, and software BANGALORE, India, Aug. 31, 2023 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage products and services, […]
SHANGHAI, China, Aug. 30, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2023 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of 30 June 2023, the company’s total revenue […]
